Partner
Laura Masurovsky is an experienced litigator with more than 25 years of practice in federal and state courts. She concentrates on patent infringement and trade secret cases and strategic counseling for portfolio growth. With a focus on the biomedical industry, Laura is an active member of Finnegan’s Israel practice.
Prior to joining Finnegan, Laura represented clients in commercial and white-collar criminal cases. She served as a special assistant U.S. attorney in the District of Columbia and as a legal advisor at the U.S. Department of State.
Laura previously served as a member of the firm’s management committee, as head of the litigation section, and as leader of the IP specialties practice group. She has been recognized by Managing Intellectual Property (MIP) as an “IP Star” and “Patent Star” on the national and regional levels as well as by The Legal 500 U.S. and Intellectual Asset Management (IAM) for her patent litigation and licensing work. The Federal Circuit Bar Association presented Laura with a Committee Leadership Award (CLA) and a Committee Individual Leadership Award (CILA) for her contributions to the Amicus Committee.
PGR2019-00043, PTAB, Judges Mitchell, Paulraj, Cotta
3:18-cv-01518, S.D. Cal., Judge Sammartino
2:10-cv-06908, E.D. Pa., Judges Angell, Savage, Cohen (Special Master)
13-1544, 16-2647, Fed. Cir., Judges Hughes, Lourie, Moore, Newman, Plager
16-1155, -1259, Fed. Cir., Judges Moore, Reyna, Taranto
1:12-cv-03846, N.D. Ill., Judge Pallmeyer
10-1500, -1520, -1521, -1522, -1523, -1524, Fed. Cir., Judges Lourie, Newman
2:07-cv-03770, D.N.J., Judges Cavanaugh, Dickson, Falk
1:16-cv-01082, D. Del., Judges Stark, Burke
Co-lead counsel for plaintiffs in consolidated ANDA cases involving Axiron®.
1:13-cv-00851, S.D. Ind., Judges Barker, Dinsmore, LaRue
Alzheimer's Institute of America, Inc. v. Avid Radiopharmaceuticals
2:10-cv-06908, E.D. Pa., Judges Angell, Savage, Cohen (Special Master)
13-1544, 16-2647, Fed. Cir., Judges Hughes, Lourie, Moore, Newman, Plager
Biogen International GmbH v. Teva Pharmaceuticals USA, Inc.
1:17-cv-00829, D. Del., Judge Noreika
1:17-cv-00116, N.D.W. Va., Judge Keeley
Cumberland Pharmaceuticals Inc. v. Mylan Institutional, LLC
Lead counsel for Cumberland in ANDA litigation and breach of contract arbitration. Successful outcome in bench trial, arbitration, arbitration fee award, and on appeal.
16-1155, -1259, Fed. Cir., Judges Moore, Reyna, Taranto
1:12-cv-03846, N.D. Ill., Judge Pallmeyer
Eli Lilly and Company v. Genentech, Inc.
PGR2019-00043, PTAB, Judges Mitchell, Paulraj, Cotta
3:18-cv-01518, S.D. Cal., Judge Sammartino
Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.
1:16-cv-00596, S.D. Ind., Judges Pratt, Brookman
Välinge Innovation AB v. Halstead New England Corporation, The Home Depot Inc. et al.
1:16-cv-01082, D. Del., Judges Stark, Burke
Webinar
Top Ten Mistakes to Avoid in Negotiating and Drafting License and Collaboration Agreements Top Ten Mistakes to Avoid in Negotiating and Drafting License and Collaboration Agreements
May 6, 2026
Webinar
Webinar
Strategies for Effectively Enhancing IP Value of Critical Assets After Teva v. Amneal and Other Recent Decisions Strategies for Effectively Enhancing IP Value of Critical Assets After Teva v. Amneal and Other Recent Decisions
June 11, 2025
Webinar
Articles
Strategies for Effectively Enhancing IP Value of Critical Assets after Teva v. Amneal and Other Recent Decisions Strategies for Effectively Enhancing IP Value of Critical Assets after Teva v. Amneal and Other Recent Decisions
May 20, 2025
The MarkerBooks
Patent Litigation Strategies Handbook, 5th Edition Patent Litigation Strategies Handbook, 5th Edition
March 4, 2025
American Bar AssociationWebinar
IP Challenges in Protecting Life Sciences Innovations IP Challenges in Protecting Life Sciences Innovations
September 18, 2024
Webinar
Articles
Global Patent Strategies in Light of Recent Case on Patent Term Global Patent Strategies in Light of Recent Case on Patent Term
May 22, 2024
The Marker/Start IsraelAward/Ranking
Finnegan Remains a Top Tier Firm in the 2025 Managing Intellectual Property IP Stars Rankings Finnegan Remains a Top Tier Firm in the 2025 Managing Intellectual Property IP Stars Rankings
May 30, 2025
Managing Intellectual PropertyAward/Ranking
Finnegan Ranks at the Top of the Managing Intellectual Property IP Stars Rankings Finnegan Ranks at the Top of the Managing Intellectual Property IP Stars Rankings
June 28, 2024
Managing Intellectual PropertyPress Release
Managing Intellectual Property IP Stars: Finnegan Scores Top Patent Rankings Across the Board Managing Intellectual Property IP Stars: Finnegan Scores Top Patent Rankings Across the Board
July 13, 2023
Managing Intellectual PropertyPress Release
Finnegan Secures a Jury Win for Under Armour in Trademark Suit Finnegan Secures a Jury Win for Under Armour in Trademark Suit
January 24, 2023
Commentary
Litigator of the Week: Standing Strong for Under Armour’s Trademarks Without Going Overboard Against Upstart Armorina Litigator of the Week: Standing Strong for Under Armour’s Trademarks Without Going Overboard Against Upstart Armorina
January 20, 2023
The AmLaw Litigation DailyCommentary
Under Armour Wins in TM Suit Against Armorina Under Armour Wins in TM Suit Against Armorina
January 13, 2023
Law360Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.